In conclusion, the genetic polymorphism of cytochromes P450 2D6, 3A4 and 3A5 does not seem to predict the clinical response to CC in our population of 77 anovulatory PCOS women. This evidence concerns the gene CYP2D6 and polycystic ovary syndrome.